Xu Zhenyu 4

What Happened

• Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 7,393 shares on July 6, 2026. The weighted average sale price reported was $5.17 per share, for total proceeds of approximately $38,242. This was a sale (not a purchase) executed to satisfy tax-withholding obligations tied to recent restricted stock unit vesting.

Key Details

• Transaction date: July 6, 2026 (Form 4 filed July 7, 2026).
• Transaction type/code: Sale (S); open-market transactions.
• Price: Weighted average $5.17; prices ranged from $4.97 to $5.43 (per footnote).
• Shares sold: 7,393; proceeds ≈ $38,242.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnotes: F1 — sales were made to satisfy tax withholding for RSUs vested July 2 and July 3, 2026, and were effected under a pre-established Rule 10b5-1(c) trading plan (non-discretionary). F2 — weighted average price; details of quantities at each price are available on request.
• Filing timeliness: Reported the next day (filed 2026-07-07 for a 2026-07-06 transaction), indicating a timely filing.

Context

• These sales were routine tax-withholding transactions tied to vested restricted stock units and were executed under a 10b5-1 plan, meaning they were pre-planned and not discretionary trades. Such sales are generally considered administrative (to cover taxes) rather than a direct signal about the insider’s view of the company.